Gain Therapeutics Inc (GANX)
3.19
-0.20
(-5.90%)
USD |
NASDAQ |
Apr 24, 16:00
3.15
-0.04
(-1.25%)
After-Hours: 20:00
Gain Therapeutics 1 Year Total Returns (Daily): -36.45% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | -36.45% |
April 23, 2024 | -37.57% |
April 22, 2024 | -41.62% |
April 19, 2024 | -36.02% |
April 18, 2024 | -35.45% |
April 17, 2024 | -33.75% |
April 16, 2024 | -34.03% |
April 15, 2024 | -35.49% |
April 12, 2024 | -31.67% |
April 11, 2024 | -25.33% |
April 10, 2024 | -29.23% |
April 09, 2024 | -29.44% |
April 08, 2024 | -28.39% |
April 05, 2024 | -23.93% |
April 04, 2024 | -23.01% |
April 03, 2024 | -17.90% |
April 02, 2024 | -19.29% |
April 01, 2024 | -20.54% |
March 28, 2024 | -19.44% |
March 27, 2024 | -21.47% |
March 26, 2024 | -22.45% |
March 25, 2024 | -25.51% |
March 22, 2024 | -17.31% |
March 21, 2024 | -15.31% |
March 20, 2024 | -13.06% |
Date | Value |
---|---|
March 19, 2024 | -8.01% |
March 18, 2024 | -5.63% |
March 15, 2024 | -2.94% |
March 14, 2024 | 1.66% |
March 13, 2024 | 9.93% |
March 12, 2024 | 24.25% |
March 11, 2024 | 27.25% |
March 08, 2024 | 20.05% |
March 07, 2024 | 20.42% |
March 06, 2024 | 30.11% |
March 05, 2024 | 18.27% |
March 04, 2024 | 19.80% |
March 01, 2024 | 17.88% |
February 29, 2024 | 7.93% |
February 28, 2024 | 7.21% |
February 27, 2024 | 7.67% |
February 26, 2024 | 7.14% |
February 23, 2024 | 7.31% |
February 22, 2024 | 5.97% |
February 21, 2024 | 8.87% |
February 20, 2024 | 13.35% |
February 16, 2024 | 17.56% |
February 15, 2024 | 23.08% |
February 14, 2024 | 19.14% |
February 13, 2024 | 12.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.64%
Minimum
May 24 2022
92.19%
Maximum
May 12 2023
-19.01%
Average
-14.43%
Median
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 92.58% |
Alpine Immune Sciences Inc | 801.8% |
Outlook Therapeutics Inc | -62.39% |
Greenwich LifeSciences Inc | 12.58% |
CEL-SCI Corp | -35.96% |